BRITANNIA LIFE SCIENCES

Research BRITANNIA LIFE SCIENCES (L020) on Bullrun: market cap EUR 7.25M, P/E 0.8. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerL020
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 7.25M
• P/E0.8
• Financial periodQ4 2025
• RevenueEUR 377.01K
• Net incomeEUR 12.13M
• Free cash flowEUR 989.01K
• Gross margin92.2%

Valuation Snapshot

latest market cap is EUR 7.25M; P/E is 0.8.

About BRITANNIA LIFE SCIENCES

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.

Frequently asked questions

What is BRITANNIA LIFE SCIENCES's market cap?

BRITANNIA LIFE SCIENCES's market capitalization is EUR 7.25M.

What is BRITANNIA LIFE SCIENCES's P/E ratio?

BRITANNIA LIFE SCIENCES's price-to-earnings (P/E) ratio is 0.8.

What does BRITANNIA LIFE SCIENCES do?

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.